FDA Import Refusal SCS-3688418-8/11/1 — Glaxosmithkline
The FDA refused shipment SCS-3688418-8/11/1 from Glaxosmithkline (United Kingdom) on Mar 13, 2019. The refused product falls under Drugs and Biologics — DICLOFENAC SODIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Mar 13, 2019
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 62GBY18 DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
- Charges
- 75